Marksans Pharma Ltd (BOM:524404) reported a strong revenue growth of 20.8% year-on-year for Q2 FY25, driven by robust performance in the US, Australia, and New Zealand markets. The US market saw a ...

Marksans Pharma added 2.70% to Rs 296.80 after the company reported 15.8% increase in consolidated net profit to Rs 96.72 crore on 20.83% rise in revenue from operations to Rs 641.92 crore in Q2 FY25 ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Trading window for the designated persons of Marksans Pharma Limited will remain closed from 1st July, 2024 until 48 hours after announcement of Unaudited Financial Results for the quarter ended ...

November 12, 2024 13:03 Stock market live today: Marksans Pharma Q2 net profit soars to ₹63.20 crore, shares rise 1.89% ...

Marksans Pharma Ltd share price was down by -3.61% from the previous closing price of ₹299.40. Who are peers of Marksans Pharma Ltd? The peers of Marksans Pharma Ltd are Sun Pharmaceuticals ...

Inspired by this, big pharma companies will now allocate 5-10% of their Companys revenues to R&D for future biotech startups, hoping it will also attract more global partners. Marksans Pharma has ...

Indiamart Intermeshs subsidiary, Tradezeal Online entered into share purchase agreement to disinvest a 26% stake in Shipway Technology by way of sale of 4,088 Compulsorily Convertible Preference ...

Marksans Pharma Limited was formerly incorporated as Tasc Pharmaceuticals Limited in April, 1982. Pursuant to the Scheme of Amalgamation, name of the Company was changed from Tasc Pharmaceuticals ...

Reliance Power, Nykaa, 3M India, Sula Vineyards, BASF India, Natco Pharma, and Rattanindia Enterprises are among other firms ...

Belt Hold Bullish 1H 68 Oct 22, 2024 11:00PM ...